These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37140928)

  • 1. Hereditary gelsolin amyloidosis: a rare cause of cranial, peripheral and autonomic neuropathies linked to D187N and Y447H substitutions.
    Mendelson L; Prokaeva T; Lau KHV; Sanchorawala V; McCausland K; Spencer B; Dasari S; McPhail ED; Kaku MC
    Amyloid; 2023 Dec; 30(4):357-363. PubMed ID: 37140928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathy Associated with Systemic Amyloidosis.
    Kaku M; Berk JL
    Semin Neurol; 2019 Oct; 39(5):578-588. PubMed ID: 31639841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Finnish gelsolin amyloidosis causes significant disease burden but does not affect survival: FIN-GAR phase II study.
    Schmidt EK; Mustonen T; Kiuru-Enari S; Kivelä TT; Atula S
    Orphanet J Rare Dis; 2020 Jan; 15(1):19. PubMed ID: 31952544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences in the clinical course of Finnish gelsolin amyloidosis.
    Atula S; Nikoskinen T; Saastamoinen A; Strbian D; Schmidt EK; Kiuru-Enari S
    Amyloid; 2016; 23(1):33-8. PubMed ID: 26805765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurological manifestations of AGel amyloidosis (Meretoja's syndrome) in a German family].
    Bürmann J; Fassbender K; Henn W; Lohse P; Holzhoffer C; Fassbender K; Dillmann U
    Fortschr Neurol Psychiatr; 2011 Apr; 79(4):238-41. PubMed ID: 21480154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing amount of amyloid are associated with the severity of clinical features in hereditary gelsolin (AGel) amyloidosis.
    Pihlamaa T; Suominen S; Kiuru-Enari S; Tanskanen M
    Amyloid; 2016 Dec; 23(4):225-233. PubMed ID: 27879149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid in parenchymal organs in gelsolin (AGel) amyloidosis.
    Schmidt EK; Kiuru-Enari S; Atula S; Tanskanen M
    Amyloid; 2019 Sep; 26(3):118-124. PubMed ID: 31122115
    [No Abstract]   [Full Text] [Related]  

  • 8. A Patient With Hereditary ATTR and a Novel AGel p.Ala578Pro Amyloidosis.
    Sridharan M; Highsmith WE; Kurtin PJ; Zimmermann MT; Theis JD; Dasari S; Dingli D
    Mayo Clin Proc; 2018 Nov; 93(11):1678-1682. PubMed ID: 30093168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hearing problems in patients with hereditary gelsolin amyloidosis.
    Mustonen T; Sivonen V; Atula S; Kiuru-Enari S; Sinkkonen ST
    Orphanet J Rare Dis; 2021 Oct; 16(1):448. PubMed ID: 34689817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xerostomia in hereditary gelsolin amyloidosis.
    Juusela P; Tanskanen M; Nieminen A; Kari K; Suominen L; Uitto VJ; Kiuru-Enari S
    Amyloid; 2013 Mar; 20(1):39-44. PubMed ID: 23356404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutis laxa in hereditary gelsolin amyloidosis.
    Kiuru-Enari S; Keski-Oja J; Haltia M
    Br J Dermatol; 2005 Feb; 152(2):250-7. PubMed ID: 15727635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtle neuropsychiatric and neurocognitive changes in hereditary gelsolin amyloidosis (AGel amyloidosis).
    Kantanen M; Kiuru-Enari S; Salonen O; Kaipainen M; Hokkanen L
    PeerJ; 2014; 2():e493. PubMed ID: 25097823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary gelsolin amyloidosis.
    Kiuru-Enari S; Haltia M
    Handb Clin Neurol; 2013; 115():659-81. PubMed ID: 23931809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe elastolysis in hereditary gelsolin (AGel) amyloidosis.
    Koskelainen S; Zhao F; Kalimo H; Baumann M; Kiuru-Enari S
    Amyloid; 2020 Jun; 27(2):81-88. PubMed ID: 31814469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular pathology in hereditary gelsolin amyloidosis.
    Kiuru-Enari S; Somer H; Seppäläinen AM; Notkola IL; Haltia M
    J Neuropathol Exp Neurol; 2002 Jun; 61(6):565-71. PubMed ID: 12071640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanobody interaction unveils structure, dynamics and proteotoxicity of the Finnish-type amyloidogenic gelsolin variant.
    Giorgino T; Mattioni D; Hassan A; Milani M; Mastrangelo E; Barbiroli A; Verhelle A; Gettemans J; Barzago MM; Diomede L; de Rosa M
    Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):648-660. PubMed ID: 30625383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe ataxia with neuropathy in hereditary gelsolin amyloidosis: a case report.
    Tanskanen M; Paetau A; Salonen O; Salmi T; Lamminen A; Lindsberg P; Somer H; Kiuru-Enari S
    Amyloid; 2007 Mar; 14(1):89-95. PubMed ID: 17453628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac manifestations in Finnish gelsolin amyloidosis patients.
    Mustonen T; Holkeri A; Holmström M; Atula S; Pakarinen S; Lehmonen L; Kiuru-Enari S; Aro AL
    Amyloid; 2021 Sep; 28(3):168-172. PubMed ID: 33877023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary gelsolin amyloidosis mimicking Sjögren's syndrome.
    Juusela P; Tanskanen M; Nieminen A; Uitto VJ; Blåfield H; Kiuru-Enari S
    Clin Rheumatol; 2009 Nov; 28(11):1351-4. PubMed ID: 19701715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological manifestations of hereditary transthyretin amyloidosis: a focus on diagnostic delays.
    Kaku MC; Bhadola S; Berk JL; Sanchorawala V; Connors LH; Lau KHV
    Amyloid; 2022 Sep; 29(3):184-189. PubMed ID: 35253562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.